دورية أكاديمية
Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
العنوان: | Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant? |
---|---|
المؤلفون: | Brian Ball, Eytan M. Stein |
المصدر: | Haematologica, Vol 104, Iss 8 (2019) |
بيانات النشر: | Ferrata Storti Foundation, 2019. |
سنة النشر: | 2019 |
المجموعة: | LCC:Diseases of the blood and blood-forming organs |
مصطلحات موضوعية: | Diseases of the blood and blood-forming organs, RC633-647.5 |
الوصف: | Minimal residual disease has emerged as an important prognostic factor for relapse and survival in acute myeloid leukemia. Eradication of minimal residual disease may increase the number of patients with long-term survival; however, to date, strategies that specifically target minimal residual disease are limited. Consensus guidelines on minimal residual disease detection by immunophenotypic and molecular methods are an essential initial step for clinical trials evaluating minimal residual disease. Here, we review promising targets of minimal residual disease prior to allogeneic stem cell transplantation. Specifically, the focus of this review is on the rationale and clinical development of therapies targeting: oncogenic driver mutations, apoptosis, methylation, and leukemic immune targets. We review the progress made in the clinical development of therapies against each target and the challenges that lie ahead. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 0390-6078 1592-8721 |
Relation: | https://haematologica.org/article/view/9000; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721 |
DOI: | 10.3324/haematol.2018.208587 |
URL الوصول: | https://doaj.org/article/9516ab1a18664542b0977b0896f5fd48 |
رقم الأكسشن: | edsdoj.9516ab1a18664542b0977b0896f5fd48 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 03906078 15928721 |
---|---|
DOI: | 10.3324/haematol.2018.208587 |